Skip to main content

Advertisement

Table 3 Mean (CI 95%) and analysis of variance (ANOVA) of baseline. 1 and 5 week Patient-Reported Outcomes

From: Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial

Self-Reported Outcomes T2: 1 week Evaluation T3: 5 week Evaluation
  Experimental (n = 20) Control (n = 20) ANOVA F(p) Experimental (n = 20) Control (n = 20) ANOVA F(p)
POMS
 Tension/Anxiety 6.05 (3.26–8.83) 6.50 (3.52–9.47) 0.05 (0.81) 5.40 (2.77–8.02) 6.50 (3.89–9.10) 0.38 (0.53)
 Depression/Dejection 8.00 (3.76–12.23) 10.05 (5.26–14.83) 0.45 (0.50) 6.35 (2.71–9.98) 9.30 (4.41–14.19) 1.02 (0.31)
 Anger/Hostility 5.40 (3.20–7.59) 5.75 (2.51–8.98) 0.03 (0.85) 4.25 (2.51–5.98) 6.60 (2.69–10.50) 1.32 (0.25)
 Vigor/Activity 24.80 (20.46–29.13) 26.70 (23.13–30.26) 0.50 (0.48) 28.10 (24.09–32.10) 25.90 (21.85–29.94) 0.65 (0.42)
 Fatigue/Inertia 8.85 (6.49–11.20) 8.75 (6.56–10.93) 0.004 (0.94) 6.40 (4.33–8.46) 8.00 (5.76–10.23) 1.21 (0.27)
 Confusion/Bewilderment 5.95 (3.10–8.79) 7.10 (3.52–10.67) 0.27 (0.60) 3.75 (0.84–6.65) 5.00 (1.55–8.44) 0.33 (0.56)
 TMD 109.90 (97.14–122.66) 111. 30 (95.33–127.27) 0.02 (0.88) 98.05 (85.33–110.77) 109.40 (93.87–124.93) 1.40 (0.24)
EORTC QLQ-C30
 Global health status/QoL 67.49 (59.50–75.48) 63.74 (56.55–70.93) 0.53 (0.47) 76.66 (69.66–83.66) 62.91 (56.15–69.66) 8.75 (0.005)
Functional scales
 Physical functioning 78.68 (69.12–88.24) 74.03 (62.34–85.71) 0.41 (0.52) 80.18 (69.45–90.90) 75.03 (63.70–86.35) 0.47 (0.49)
 Role functioning 85.83 (73.88–97.77) 70.83 (54.85–86.81) 2.47 (0.12) 91.66 (82.71–100.61) 79.16 (68.76–89.56) 3.63 (0.06)
 Emotional functioning 83.78 (75.36–92.20) 77.96 (65.83–90.09) 0.68 (0.41) 85.90 (78.35–93.45) 81.36 (71.89–90.83) 0.61 (0.43)
 Cognitive functioning 91.76 (82.02–101.30) 84.99 (73.42–96.56) 0.85 (0.36) 92.49 (84.70–100.28) 84.16 (72.71–95.61) 1.58 (0.21)
 Social functioning 87.49 (74.87–100.12) 86.66 (75.46–97.86) 0.01 (0.91) 91.66 (81.70–101.63) 94.99 (89.28–100.71) 0.36 (0.54)
Symptoms scales
 Fatigue 26.62 (18.62–34.61) 37.76 (28.16–47.37) 3.48 (0.07) 21.62 (12.46–30.78) 39.42 (28.55–50.30) 6.87 (0.01)
 Nausea and vomiting 0.00 (0.00–0.00) 0.83 (−0.91–2.57) 1.00 (0.32) 1.66 (− 0.73–4.06) 0.00 (0.00–0.00) 2.11 (0.15)
 Pain 29.16 (17.88–40.44) 31.66 (20.37–42.95) 0.10 (0.74) 19.99 (10.00–29.94) 34.16 (24.20–44.11) 4.41 (0.04)
 Dyspnoea 5.00 (−5.46–15.46) 8.33 (− 2.84–19.50) 0.20 (0.65) 3.33 (− 3.64–10.30) 4.99 (− 2.63–12.63) 0.11 (0.73)
 Insomnia 29.99 (14.89–45.09) 29.99 (14.89–45.09) 0.00 (1.00) 23.33 (9.84–36.81) 23.33 (8.92–37.73) 0.00 (1.00)
 Appetite loss 11.66 (1.20–22.12) 18.33 (1.95–34.71) 0.51 (0.47) 11.66 (1.20–22.12) 14.99 (3.15–26.84) 0.19 (0.66)
 Constipation 1.66 (−1.82–5.15) 9.99 (−0.24–20.24) 2.59 (0.11) 1.66 (−1.82–5.15) 6.66 (−2.93–16.26) 1.04 (0.31)
 Diarrhoea 8.33 (−0.24–16.91) 4.99 (−2.63–12.63) 0.36 (0.54) 3.33 (− 1.46–8.13) 8.33 (− 0.24–16.91) 1.13 (0.29)
 Financial difficulties 3.33 (3.64–10.30) 8.33 (− 1.63–18.29) 0.74 (0.39) 3.33 (− 3.64–10.30) 4.99 (− 2.63–12.63) 0.11 (0.73)
 VAS 6.10 (5.44–6.76) 6.15 (5.26–7.04) 0.009 (0.92) 4.90 (4.03–5.77) 6.45 (5.65–7.25) 7.56 (0.009)
 SFI 67.20 (60.36–74.03) 59.80 (53.77–65.82) 2.88 (0.09) 66.80 (57.08–76.51) 59.20 (53.41–64.98) 1.97 (0.16)
 ULFI 72.60 (65.38–79.81) 72.20 (67.36–77.03) 0.009 (0.92) 72.40 (62.64–82.15) 70.60 (64.36–76.83) 0.10 (0.74)
 BAI 0.42 (0.32–0.51) 0.44 (0.31–0.57) 0.11 (0.73) 0.33 (0.24–0.43) 0.40 (0.27–0.56) 0.83 (0.36)
 MBS 0.19 (0.59–0.32) 0.33 (0.19–0.46) 2.46 (0.12) 0.17 (0.05–0.28) 0.33 (0.18–0.47) 3.23 (0.08)
 BADIX 0.35 (0.25–0.45) 0.42 (0.30–0.54) 0.84 (0.36) 0.28 (0.19–0.37) 0.39 (0.26–0.51) 2.16 (0.14)
  1. Abbreviations: POMS Profile of Mood States, TMD Total Emotional Distortion, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer (EORT) Quality of Life Questionnaire QLQ-C30, QoL Quality of Life, VAS Visual Analogue Scale, SFI Spine Functional Index, ULFI Upper Limb Functional Index, BAI Backache Index, MBS Morning Stiffness Score, BADIX Backache Disability Index